Literature DB >> 31171639

Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia.

Fiorina Giona1, Isabella Massimi2, Maria Luisa Guarino2, Michelina Santopietro3, Marica Laurino3, Flavia Temperilli2, Giovanna Palumbo3, Robin Foà3, Fabio Maria Pulcinelli2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31171639      PMCID： PMC7012476          DOI： 10.3324/haematol.2019.226266

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.

Authors:  Fiorina Giona; Luciana Teofili; Maria Luisa Moleti; Maurizio Martini; Giovanna Palumbo; Angela Amendola; Maria Gabriella Mazzucconi; Anna Maria Testi; Patrizia Pignoloni; Sonia Maria Orlando; Sara Capodimonti; Mauro Nanni; Giuseppe Leone; Luigi Maria Larocca; Robin Foà
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

2.  Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets.

Authors:  Flavia Temperilli; Manuela Di Franco; Isabella Massimi; Maria Luisa Guarino; Maria Paola Guzzo; Guido Valesini; Luigi Frati; Fabio M Pulcinelli
Journal:  Vascul Pharmacol       Date:  2015-07-02       Impact factor: 5.773

3.  Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity.

Authors:  Laura Alemanno; Isabella Massimi; Vanessa Klaus; Maria Luisa Guarino; Teresa Maltese; Luigi Frati; Dominick J Angiolillo; Fabio M Pulcinelli
Journal:  Thromb Haemost       Date:  2018-02-15       Impact factor: 5.249

4.  Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.

Authors:  Flavia Temperilli; Aldona Rina; Isabella Massimi; Anna Lisa Montemari; Maria Luisa Guarino; Alessandra Zicari; Fabio M Pulcinelli
Journal:  Platelets       Date:  2015-03-03       Impact factor: 3.862

5.  Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target.

Authors:  Silvia Pascale; Giovanna Petrucci; Alfredo Dragani; Aida Habib; Francesco Zaccardi; Francesca Pagliaccia; Davide Pocaterra; Enzo Ragazzoni; Giancarlo Rolandi; Bianca Rocca; Carlo Patrono
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

6.  The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia.

Authors:  Luciana Teofili; Fiorina Giona; Maurizio Martini; Tonia Cenci; Francesco Guidi; Lorenza Torti; Giovanna Palumbo; Angela Amendola; Giuseppe Leone; Robin Foà; Luigi M Larocca
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

7.  Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment.

Authors:  Giulio La Rosa; Luigi M Biasucci; Claudia Mandolini; Isabella Massimi; Giorgia Copponi; Fabio M Pulcinelli; Filippo Crea
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2018-10       Impact factor: 2.160

8.  Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo.

Authors:  Li-Ming Lien; Zhih-Cherng Chen; Chi-Li Chung; Ting-Lin Yen; Hou-Chang Chiu; Duen-Suey Chou; Shih-Yi Huang; Joen-Rong Sheu; Wan-Jung Lu; Kuan-Hung Lin
Journal:  Eur J Pharmacol       Date:  2014-05-15       Impact factor: 4.432

9.  Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.

Authors:  Isabella Massimi; Raffaella Guerriero; Lavinia Vittoria Lotti; Valentina Lulli; Alessandra Borgognone; Federico Romani; Francesco Barillà; Carlo Gaudio; Marco Gabbianelli; Luigi Frati; Fabio M Pulcinelli
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

10.  MiR-21 role in aspirin-dependent PPARα and multidrug resistance protein 4 upregulation.

Authors:  Isabella Massimi; Laura Alemanno; Maria L Guarino; Raffaella Guerriero; Luigi Frati; Luigi Biasucci; Fabio M Pulcinelli
Journal:  Res Pract Thromb Haemost       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.